Explore 6 Maryland biotech companies with recent funding, ready to bring their breakthrough technologies to the clinic.

Voyager Acquisition Corporation (NASDAQ: 'VACHU,” 'VACH,” 'VACHW”) ('Voyager” or the 'Company”) held the general meeting on March 12, 2026 and approved the previously announced business combination ...

Voyager Acquisition Corporation (NASDAQ: "VACHU," "VACH," "VACHW") ("Voyager" or the "Company") held the general meeting on March 12, 2026 and approved ...

Speculation began swirling this month about cuts to the ArtQuest program orchestrated through student scheduling changes and staff layoffs linked to Santa Rosa City Schools budget woes.

Voyager Acquisition Corporation (NASDAQ: "VACHU," "VACH," "VACHW") ("Voyager" or the "Company") held the general meeting on March 12, 2026 and approved ...

Columbia Global Technology Fund returned 1.97% in Q4 2025, led by AI demand despite benchmark underperformance. Read the full ...

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2025 Earnings Call Transcript March 12, 2026 Operator: Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics, Inc. fourth quarter ...

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biotechnology company developing new medicines to treat pain and neuropathy, today announced financial results for the ...

FIRST SITE INITIATION VISIT COMPLETED IN AUSTRALIASARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a ...

Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDTCompany ParticipantsRyan Cohlhepp - ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...